Valvular Heart Disease
126
27
32
54
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Research Maturity
54 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.2%
4 terminated out of 126 trials
93.1%
+6.6% vs benchmark
9%
11 trials in Phase 3/4
17%
9 of 54 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 54 completed trials
Clinical Trials (126)
Longitudinal Validation of CIRC Technologies
Prehabilitation for Patients Undergoing Elective Cardiac Surgery
Optimized Expansion of the Implanted Transcatheter Aortic Valve
Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation
Abbott Structural Heart Device Registry
A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease
Evaluation and Validation of Management Strategy for Conductive Disorders After TAVR (EVATAVI)
MULTIVALVE : A Prospective Multicentre Study of Multiple and Mixed Valvular Heart Disease
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Diagnostic Study of Structural Heart Disease Based on Cardiac Electromechanical Signals
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions
Comparing Measurements of the Aortic Valve Taken During Surgery With Those Obtained Before Surgery Using Computed Tomography Scans, in Patients Undergoing Surgical Aortic Valve Replacement
Development of CIRC Technologies
DELINEATE-Prospective
Cardiovascular Acoustics for Early Disease Detection
PPG to Predict Ejection Fraction and Other Echographic Data in the General Population
NHLBI Transmural Electrosurgery LeafLet Traversal And Laceration Evaluation (TELLTALE) BASILICA-TAVR Trial
Echocardiographic Screening of Pregnant Women During Antenatal Care
In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm